{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-8TOLOG5X/5c68-367023b-bb-149-ade75ba2354a346a/PDF","dcterms:extent":"8011 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-8TOLOG5X/5e33ebcd-1c52-431a-93aa-1f117f259383/TEXT","dcterms:extent":"0 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-8TOLOG5X/01aedbc8-b437-493b-a253-665ab32a6547/WEB","dcterms:extent":"0 KB"}],"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:DOC-8TOLOG5X","dcterms:issued":"2016","dc:contributor":["Anderluh, Marko","Tomašič, Tihomir"],"dc:creator":"Jug, Gregor","dc:format":{"@xml:lang":"sl","#text":"VI, 221 str., 30 cm"},"dc:identifier":["COBISSID:285154048","PID:https://repozitorij.uni-lj.si/IzpisGradiva.php?id=143763","URN:URN:NBN:SI:doc-8TOLOG5X"],"dc:language":["en","sl"],"dc:publisher":{"@xml:lang":"sl","#text":"G. Jug"},"dc:source":{"@xml:lang":"sl","#text":"visokošolska dela"},"dc:subject":[{"@xml:lang":"sl","#text":"antagonisti"},{"@xml:lang":"sl","#text":"DC-SIGN"},{"@xml:lang":"sl","#text":"disertacije"},{"@xml:lang":"sl","#text":"infekcije"},{"@xml:lang":"sl","#text":"lektini tipa C"},{"@xml:lang":"sl","#text":"molekulsko modeliranje"},{"@xml:lang":"sl","#text":"patogeni"},{"@xml:lang":"sl","#text":"računalniško podprto načrtovanje"},{"@xml:lang":"sl","#text":"sidranje"},{"@xml:lang":"sl","#text":"validacija"},{"@xml:lang":"sl","#text":"virus HIV"}],"dc:title":{"@xml:lang":"sl","#text":"Uporaba molekulskega modeliranja pri načrtovanju antagonistov DC-SIGN in in vitro vrednotenje njihovega učinka| doktorska disertacija| Use of molecular modelling for design of DC-SIGN antagonists and their in vitro evaluation|"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"visokošolska dela"},{"@xml:lang":"en","#text":"theses and dissertations"},{"@rdf:resource":"http://www.wikidata.org/entity/Q1266946"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:DOC-8TOLOG5X","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:DOC-8TOLOG5X"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:DOC-8TOLOG5X/5c68-367023b-bb-149-ade75ba2354a346a/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Univerza v Ljubljani, Fakulteta za farmacijo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:DOC-8TOLOG5X/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:DOC-8TOLOG5X"}}}}